Literature DB >> 1744166

Effects of radiation fractionation on four squamous cell carcinoma lines with dissimilar inherent radiation sensitivity.

K Pekkola-Heino1, J Kulmala, P Klemi, T Lakkala, K Aitasalo, H Joensuu, R Grenman.   

Abstract

The effect of radiation fractionation was investigated using a new 96-well-plate clonogenic assay in four squamous cell carcinoma lines. Earlier experiments had shown that two of the cell lines (UT-SCC-1A and UM-SCC-14A) were inherently relatively sensitive to irradiation, and two (UM-SCC-1 and UM-SCV-1A) relatively resistant. All of the four carcinomas from which the cell lines were established had poor clinical outcome. The radiation doses were given as a single exposure, or split into two or three equal fractions with a 24-h interval. The two inherently sensitive cell lines showed enhanced survival after radiation fractionation as compared with a single dose, whereas the resistant cell lines did not. The result suggests that both the inherent resistance of cancer cells to irradiation and the repair of sublethal radiation damage may lead to treatment failure, and that shortening of the total irradiation time may overcome cancer cell recovery between fractions in some, but not in all carcinomas.

Entities:  

Mesh:

Year:  1991        PMID: 1744166     DOI: 10.1007/bf01613295

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  Radiation response of mammalian cells grown in culture. 1. Repair of X-ray damage in surviving Chinese hamster cells.

Authors:  M M ELKIND; H SUTTON
Journal:  Radiat Res       Date:  1960-10       Impact factor: 2.841

2.  Local control of squamous carcinoma of oral cavity and oropharynx with 3 vs 5 treatment fractions per week.

Authors:  R W Byhardt; M Greenberg; J D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 May-Jun       Impact factor: 7.038

3.  Radiosensitivity of head and neck cancer cells in vitro. A 96-well plate clonogenic cell assay for squamous cell carcinoma.

Authors:  R Grenman; D Burk; E Virolainen; J G Wagner; A S Lichter; T E Carey
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1988-04

Review 4.  The radiobiology of human cells and tissues. In vitro radiosensitivity. The picture has changed in the 1980s.

Authors:  G G Steel; T J McMillan; J H Peacock
Journal:  Int J Radiat Biol       Date:  1989-11       Impact factor: 2.694

5.  Faster repair of DNA double-strand breaks in radioresistant human tumor cells.

Authors:  J L Schwartz; J Rotmensch; S Giovanazzi; M B Cohen; R R Weichselbaum
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-10       Impact factor: 7.038

6.  Correlation between PLD repair capacity and the survival curve of human fibroblasts in exponential growth phase: analysis in terms of several parameters.

Authors:  B Fertil; P J Deschavanne; D Debieu; E P Malaise
Journal:  Radiat Res       Date:  1988-10       Impact factor: 2.841

7.  A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck.

Authors:  J T Parsons; F J Bova; R R Million
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-12       Impact factor: 7.038

8.  Radiation response characteristics of human cells in vitro.

Authors:  E J Hall; M Marchese; T K Hei; M Zaider
Journal:  Radiat Res       Date:  1988-06       Impact factor: 2.841

9.  Radiation response of vulvar squamous cell carcinoma (UM-SCV-1A, UM-SCV-1B, UM-SCV-2, and A-431) cells in vitro.

Authors:  K Pekkola-Heino; J Kulmala; S Grenman; T E Carey; R Grenman
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

10.  Radiation therapy for advanced head and neck squamous-cell carcinoma using twice-a-day fractionation.

Authors:  E Medini; Y Rao; T Kim; T K Jones; S H Levitt
Journal:  Radiology       Date:  1980-02       Impact factor: 11.105

View more
  9 in total

1.  The intrinsic radiosensitivity and sublethal damage repair capacity of five cervical carcinoma cell lines tested with the 96-well-plate assay.

Authors:  V Rantanen; S Grénman; J Kulmala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

2.  Comparison of cellular radiosensitivity between different localizations of head and neck squamous-cell carcinoma.

Authors:  K Pekkola-Heino; M Jaakkola; J Kulmala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 3.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

4.  Sublethal damage repair after fractionated irradiation in endometrial cancer cell lines tested with the 96-well plate clonogenic assay.

Authors:  V Rantanen; S Grénman; J Kulmala; K Alanen; T Lakkala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

5.  Impaired NHEJ function in multiple myeloma.

Authors:  Clara Yang; Christopher Betti; Sheetal Singh; Amir Toor; Andrew Vaughan
Journal:  Mutat Res       Date:  2008-11-05       Impact factor: 2.433

6.  Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer.

Authors:  Zhixiang Wu; Jessica B Doondeea; Amin Moghaddas Gholami; Melanie C Janning; Simone Lemeer; Karl Kramer; Suzanne A Eccles; Susanne M Gollin; Reidar Grenman; Axel Walch; Stephan M Feller; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2011-09-28       Impact factor: 5.911

7.  Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma.

Authors:  Ryoji Kitamura; Takeshi Toyoshima; Hideaki Tanaka; Shintaro Kawano; Takahiro Kiyosue; Ryota Matsubara; Yuichi Goto; Mitsuhiro Hirano; Kazunari Oobu; Seiji Nakamura
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-03       Impact factor: 4.553

8.  CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance.

Authors:  Sami Ventelä; Eleonora Sittig; Leni Mannermaa; Juho-Antti Mäkelä; Jarmo Kulmala; Eliisa Löyttyniemi; Leena Strauss; Olli Cárpen; Jorma Toppari; Reidar Grénman; Jukka Westermarck
Journal:  Oncotarget       Date:  2015-01-01

9.  Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.

Authors:  V Rantanen; S Grénman; J Kulmala; R Grénman
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.